Financial Daily from THE HINDU group of publications
Tuesday, Dec 13, 2005


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate - Awards & Honours


Natco bags patent appreciation award

Our Bureau

Hyderabad , Dec 12

NATCO Pharma Ltd has announced that the Indian Drug Manufacturers' Association (IDMA) has selected it for the Patent Appreciation Award.

In a release on Monday, the company said that the national level award would be given to it at a function to be held at Mumbai on December 17.

The Maharashtra Chief Minister, Mr Vilasrao Deshmukh, would present the award.

Natco said that it has been selected for the award based on the patents that it obtained — soft gel capsule resistant to gastric juices (EPO and Germany), inhaler design (Canada and Japan), and improved processes for the preparation of high purity Citalopram and Curcumin (India).

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

More Stories on : Awards & Honours



Stories in this Section
JK Cement promoter to offload 26 pc stake


Bhagyanagar Metals shortlisted for two housing projects
Ucal Fuel to exit joint venture with Engelhard
Aurobindo Pharma ARV drug in WHO list
Eastern Silk to issue Rs 200-cr FCCBs to fund expansion plans
Natco bags patent appreciation award
McLeod Russel close to acquiring Doom Dooma Tea — Size of deal likely to be Rs 50-60 cr
Opto Circuits buys German stent co
Apollo board clears 51% stake buy in Imperial
M&M to acquire 88.41 pc equity stake in Plexion
Carborundum Universal sets up unit in UAE
JRG, UAE Group in pact for stock, commodity broking operations
TRL promoters to hold talks with Indian Bank
PSU recast board okays FACT revival package
Bajaj plans fresh bike, scooter rollouts in 2006


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line